Forschungs- und Innovantionspreis für Urologische Onkologie

2016
Dr. Renate Pichler, Innsbruck
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical bacillus calmette-guérin therapy in bladder cancer

2015
PD Dr. Jörg Ellinger, Bonn
Identification of novel long non-coding RNAs in clear cell renal cell carcinoma

2014
J. Heinzelmann, Homburg/Saar
MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases

W. Jager, Mainz
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach

2013
Heidegger, I., Innsbruck
Diverse Functions of IGF/Insulin Signaling in Malignant and Noncancerous Prostate Cells: Proliferation in Cancer Cells and Differentiation in Noncancerous Cells

2012
Hofer, J., Innsbruck
PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21

2011
Ohlmann, C.-H., Markert, E., Gerharz, M., Dienes, H.-P., Stockle, M., Engelmann, U., Heidenreich, A.
Improving the Efficacy of Targeted Trials by Multiple-marker Analysis in Castrationresistant Prostate Cancer

Roos, F., R., Roberts, A. M., Hwang, I. L., Moriyama, E. H., Evans, A. J., Sybingco, S., Warson, I. R., Carneiro, L. A. M., Gedye, C., Girardin, S., E., Ailles, L. E., Jewett, M. A S., Milosevic, M., Wilson, B. C., Bell, J. C., Der, S. D., Ohh, M.
Oncolytic Targeting of Renal Cell Carcinoma via Encephalomyocarditis Virus

2010
Kruck, S., Bedke, J., Hennenlotter, J., Ohneseit, P.A., Kuehs, U., Senger, E., Sievert, K.-D., Stenzl, A., Tübingen Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression

2009
Tezval, H., Hannover
Urocortin and corticotropin releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation

2008
Grünwald, V., De Graffenried, L., Russel, D., Friedrichs, W.E., Ray, R.B., Hidalgo, M., Hannover
Inhibitors of m TOR Reverse Doxorubicin Resistance Conferred by PTEN Status in Prostate Cancer Cells

zurück